Bowen Acquisition Merging with Shenzhen Qianzhi BioTech in $75M Deal

Bowen Acquisition Corp announced a merger agreement with Shenzhen Qianzhi , which is engaged in development, manufacturing and sales of ozonated health and wellness products in .

The 's shareholders will receive 7,246,377 Bowen shares, which closed Jan. 18 at $10.36. That would equate to a purchase price of just over $75 million.

Shareholders in the combined company would have the right to receive up to an additional 1.4 million shares upon the achievement of certain earnout targets. 

Bowen raised raised $69 million in an last July.

Read more.


Source: Bowen Acquisition Merging with Shenzhen Qianzhi BioTech in M Deal